181 related articles for article (PubMed ID: 30753655)
1. Editorial for Treatment-Resistant Depression (TRD).
Kasper S; Frazer A
Int J Neuropsychopharmacol; 2019 Feb; 22(2):83-84. PubMed ID: 30753655
[No Abstract] [Full Text] [Related]
2. The role of GRIK4 gene in treatment-resistant depression.
Milanesi E; Bonvicini C; Congiu C; Bortolomasi M; Gainelli G; Gennarelli M; Minelli A
Genet Res (Camb); 2015 Jul; 97():e14. PubMed ID: 26139080
[TBL] [Abstract][Full Text] [Related]
3. Association of thalamic hyperactivity with treatment-resistant depression and poor response in early treatment for major depression: a resting-state fMRI study using fractional amplitude of low-frequency fluctuations.
Yamamura T; Okamoto Y; Okada G; Takaishi Y; Takamura M; Mantani A; Kurata A; Otagaki Y; Yamashita H; Yamawaki S
Transl Psychiatry; 2016 Mar; 6(3):e754. PubMed ID: 26954981
[TBL] [Abstract][Full Text] [Related]
4. Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts.
Fabbri C; Hagenaars SP; John C; Williams AT; Shrine N; Moles L; Hanscombe KB; Serretti A; Shepherd DJ; Free RC; Wain LV; Tobin MD; Lewis CM
Mol Psychiatry; 2021 Jul; 26(7):3363-3373. PubMed ID: 33753889
[TBL] [Abstract][Full Text] [Related]
5. Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion.
Chen MH; Li CT; Lin WC; Hong CJ; Tu PC; Bai YM; Cheng CM; Su TP
J Affect Disord; 2018 Dec; 241():1-7. PubMed ID: 30081380
[TBL] [Abstract][Full Text] [Related]
6. A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression.
McCarthy MJ; Chen Y; Demodena A; Leckband SG; Fischer E; Golshan S; Suppes T; Kelsoe JR
J Psychopharmacol; 2021 Aug; 35(8):992-1002. PubMed ID: 33938307
[TBL] [Abstract][Full Text] [Related]
7. Role of glutamate receptors and glial cells in the pathophysiology of treatment-resistant depression.
Kim YK; Na KS
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():117-26. PubMed ID: 27046518
[TBL] [Abstract][Full Text] [Related]
8. A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping.
Fabbri C; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Uher R; Lewis CM; Serretti A
Transl Psychiatry; 2020 Feb; 10(1):50. PubMed ID: 32066715
[TBL] [Abstract][Full Text] [Related]
9. Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.
Fabbri C; Corponi F; Albani D; Raimondi I; Forloni G; Schruers K; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Cristalli CP; Mantovani V; Mendlewicz J; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():203-210. PubMed ID: 28989100
[TBL] [Abstract][Full Text] [Related]
10. Brain microstructural abnormalities revealed by diffusion tensor images in patients with treatment-resistant depression compared with major depressive disorder before treatment.
Zhou Y; Qin LD; Chen J; Qian LJ; Tao J; Fang YR; Xu JR
Eur J Radiol; 2011 Nov; 80(2):450-4. PubMed ID: 20634013
[TBL] [Abstract][Full Text] [Related]
11. Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: Reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD).
Chen MH; Lin WC; Wu HJ; Cheng CM; Li CT; Hong CJ; Tu PC; Bai YM; Tsai SJ; Su TP
J Affect Disord; 2019 May; 251():162-169. PubMed ID: 30925267
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale.
Jacobsen JPR; Krystal AD; Krishnan KRR; Caron MG
Trends Pharmacol Sci; 2016 Nov; 37(11):933-944. PubMed ID: 27692695
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of low-dose ketamine infusion in anxious vs nonanxious depression: revisiting the Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression.
Chen MH; Lin WC; Wu HJ; Bai YM; Li CT; Tsai SJ; Hong CJ; Tu PC; Cheng CM; Su TP
CNS Spectr; 2021 Aug; 26(4):362-367. PubMed ID: 32419678
[TBL] [Abstract][Full Text] [Related]
14. Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder.
Gronemann FH; Petersen J; Alulis S; Jensen KJ; Riise J; Ankarfeldt MZ; Solem EJ; Bødker N; Osler M
J Affect Disord; 2021 May; 287():204-213. PubMed ID: 33799039
[TBL] [Abstract][Full Text] [Related]
15. Can Machine Learning help us in dealing with treatment resistant depression? A review.
Pigoni A; Delvecchio G; Madonna D; Bressi C; Soares J; Brambilla P
J Affect Disord; 2019 Dec; 259():21-26. PubMed ID: 31437696
[TBL] [Abstract][Full Text] [Related]
16. Treatment-resistant depression: a challenge for future research.
Kasper S
Acta Neuropsychiatr; 2014 Jun; 26(3):131-3. PubMed ID: 25279416
[No Abstract] [Full Text] [Related]
17. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.
Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J
J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066
[TBL] [Abstract][Full Text] [Related]
18. Blunted amygdala activity is associated with depression severity in treatment-resistant depression.
Ferri J; Eisendrath SJ; Fryer SL; Gillung E; Roach BJ; Mathalon DH
Cogn Affect Behav Neurosci; 2017 Dec; 17(6):1221-1231. PubMed ID: 29063521
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics in psychiatry: Clinical case of resistant depression and a previous history of multiple adverse effects.
Aguilar E; Monreal JA; Palao DJ
Actas Esp Psiquiatr; 2017 Nov; 45(6):303-6. PubMed ID: 29199764
[No Abstract] [Full Text] [Related]
20. Use of Ketamine in Elderly Patients with Treatment-Resistant Depression.
Medeiros da Frota Ribeiro C; Riva-Posse P
Curr Psychiatry Rep; 2017 Nov; 19(12):107. PubMed ID: 29138992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
